Assignee
CRITITECH INC
US·33 granted patents·24 pending applications·304 citations·filing 2007–2025
Top patents by PatentIndex Score
57 records- 0197US9814685B2Taxane particles and their useCRITITECH INC·Filed 2016·Granted Nov 14, 2017·40 cites·18 claims
- 0296US10729673B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted Aug 4, 2020·11 cites·22 claims
- 0396US10391090B2Methods for solid tumor treatmentCRITITECH INC·Filed 2018·Granted Aug 27, 2019·16 cites·26 claims
- 0496US9918957B2Methods for making compound particlesCRITITECH INC·Filed 2017·Granted Mar 20, 2018·23 cites·18 claims
- 0596US7744923B2Method for precipitation of small medicament particles into use containersCRITITECH INC·Filed 2007·Granted Jun 29, 2010·48 cites·34 claims
- 0695US10894045B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jan 19, 2021·11 cites·22 claims
- 0795US10874660B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Dec 29, 2020·10 cites·20 claims
- 0895US10507195B2Taxane particles and their useCRITITECH INC·Filed 2018·Granted Dec 17, 2019·18 cites·28 claims
- 0994US10507181B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Dec 17, 2019·10 cites·23 claims
- 1094US10398646B2Methods for treating lung disordersCRITITECH INC·Filed 2018·Granted Sep 3, 2019·10 cites·20 claims
- 1193US8778181B1Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2013·Granted Jul 15, 2014·64 cites·28 claims
- 1292US9233348B2Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2014·Granted Jan 12, 2016·32 cites·25 claims
- 1391US11123322B2Taxane particles and their useCRITITECH INC·Filed 2019·Granted Sep 21, 2021·2 cites·18 claims
- 1490US2025186390A1Taxane Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 1589US11033542B2Methods for solid tumor treatmentCRITITECH INC·Filed 2019·Granted Jun 15, 2021·2 cites·24 claims
- 1686US12329858B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 1786US10993927B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted May 4, 2021·1 cites·18 claims
- 1884US11458133B2Methods for solid tumor treatmentCRITITECH INC·Filed 2020·Granted Oct 4, 2022·1 cites·22 claims
- 1984US11058639B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2020·Granted Jul 13, 2021·1 cites·24 claims
- 2084US9925512B2Equipment assembly for and method of processing particlesCRITITECH INC·Filed 2015·Granted Mar 27, 2018·3 cites·22 claims
- 2183US12128131B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·18 claims
- 2282US12390459B2Methods for solid tumor treatmentCRITITECH INC·Filed 2022·Granted Aug 19, 2025·0 cites·20 claims
- 2382US10751319B2Collection device and methods for useCRITITECH INC·Filed 2016·Granted Aug 25, 2020·1 cites·14 claims
- 2480US11918691B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2023·Granted Mar 5, 2024·0 cites·14 claims
- 2580US11737972B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·18 claims
- 2679US2021393569A1Taxane Particles and Their UseCRITITECH INC·Filed 2021·Application pending·0 cites
- 2775US11160754B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Nov 2, 2021·0 cites·25 claims
- 2874US11583499B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2021·Granted Feb 21, 2023·0 cites·21 claims
- 2974US2024226116A1Glucocorticoid Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 3074US2020405684A1Taxane Particles and Their UseCRITITECH INC·Filed 2020·Application pending·0 cites
- 3173US12029818B2Lapatinib particles and uses thereofCRITITECH INC·Filed 2022·Granted Jul 9, 2024·0 cites·17 claims
- 3273US11523983B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 3370US2019254957A1Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 3470US2022096423A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2021·Application pending·0 cites
- 3570US2025360166A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2025·Application pending·0 cites
- 3668US11738014B2Niraparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 3768US11738029B2Rucaparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 3868US11291646B2Nozzle assembly and methods for useCRITITECH INC·Filed 2016·Granted Apr 5, 2022·0 cites·22 claims
- 3967US11931368B2Glucocorticoid “nintedanib” particles and their useCRITITECH INC·Filed 2018·Granted Mar 19, 2024·0 cites·8 claims
- 4067US2019209515A1Treatment of Bladder Cancer by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 4167US2019209514A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 4266US11104663B2Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2018·Granted Aug 31, 2021·0 cites·19 claims
- 4365US2024216424A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2022·Application pending·0 cites
- 4463US2016374953A1Methods for Making Compound ParticlesCRITITECH INC·Filed 2016·Application pending·0 cites
- 4563US2021387961A1Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2021·Application pending·0 cites
- 4662US2024156861A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 4762US2023364021A1Sorafenib particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 4861US2022023215A1Lapatinib particles and uses thereofCRITITECH INC·Filed 2021·Application pending·0 cites
- 4961US2021214683A1Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 5058US2018221849A1Equipment Assembly for and Method of Processing ParticlesCRITITECH INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →